Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0015695 (
fatty liver
)
13,941
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
cellular repressor of E1A-stimulated genes
(
CREG
) is a 220 amino acid glycoprotein structurally similar to oxidoreductases. However,
CREG
does not have enzymatic activities because it cannot bind to the cofactor flavin mononucleotide. Although
CREG
can be secreted, it is mainly an intracellular protein localized in the endocytic-lysosomal compartment. It undergoes proteolytic maturation mediated by lysosomal cysteine proteases. Biochemical studies have demonstrated that
CREG
interacts with mannose-6-phosphate/insulin-like growth factor-2 receptor (M6P/IGF2R) and exocyst Sec8.
CREG
inhibits proliferation and induces differentiation and senescence when overexpressed in cultured cells. In Drosophila, RNAi-mediated knockdown of
CREG
causes developmental lethality at the pupal stage. In mice, global deletion of the CREG1 gene leads to early embryonic death. These findings establish an essential role for
CREG
in development. CREG1 haploinsufficient and liver-specific knockout mice are susceptible to high fat diet-induced obesity,
hepatic steatosis
and insulin resistance. The purpose of this review is to provide an overview of what we know about the biochemistry and biology of
CREG
and to discuss the important questions that remain to be addressed in the future.
...
PMID:The Structure and Biological Function of CREG. 3041 97